TELMISARTAN MARKET ANALYSIS

Telmisartan Market, By Composition (Single and Combinational), By Indication (Hypertension, Nephropathy, Hepatorenal Syndrome, Cardiac Arrest, Stroke), By Dosage Form (Tablets, Capsules, Injection, Oral suspension), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In May 2024, Akums Drugs and Pharmaceuticals launched Amlodipine, Telmisartan & Metoprolol (ER) film coated tablets, a fixed-dose combination medication for managing essential hypertension with stable coronary artery disease. Approved by the Drugs Controller General of India (DCGI), this innovative formulation integrates the therapeutic benefits of calcium channel blockers, angiotensin II receptor antagonists, and beta-adrenergic blockers into a single tablet.